Zurich, Switzerland, February 28, 2012 / B3C newswire / - Haselmeier, a leading designer and manufacturer of pen injection systems, announced that it will establish a new manufacturing facility in Bangalore, India to produce and supply high-quality, competitively priced pen injectors for the pharmaceutical industry in India. The reusable and easy-to-use pen is based on the i-pen technology and designed to allow accurate and reliable dosing.
Haselmeier’s new facility will cover approx. 1.100 square meters including a clean room suite for the assembly of reusable pens. The manufacturing capacity can be swiftly adapted to changing market needs.
“As the incidence of diabetes is increasing significantly in India and other developing countries and with it the demand for injection pens will also increase”, commented Jochen Gabriel, Chairman of Haselmeier. He added that “device manufacturers will be faced with supplying high quality and affordable pen injectors in those countries. By establishing production in India, we will be well prepared for this challenge.”
Haselmeier India Pvt. Ltd. has been incorporated in August 2011. In the meantime, the company has acquired a suitable location and hired key personnel to prepare for production readiness within the shortest possible time.
The new facility will expand Haselmeier's manufacturing capacity, which currently consists of facilities in Germany and the Czech Republic. Haselmeier plans to build its own facility in India within the next years which will foresee vertical integration of crucial manufacturing steps, such as injection moulding and printing.
About Haselmeier GmbH
Haselmeier is a leading designer and manufacturer of pen and auto-injection systems. The Company’s devices feature unique function, design and technology and are marketed by leading pharmaceutical and biotechnology companies around the world.
Contact
Haselmeier GmbH
Nadia Di Secli
Dufourstr. 32
CH-8008 Zürich
Switzerland
+ 41 44 250 52 40
This email address is being protected from spambots. You need JavaScript enabled to view it.